Sumitomo Dainippon Pharma (Japan)
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Sumitomo Dainippon Pharma (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
43%
Total
Publications
1.9K
Total Open
Publications
829
Total
Citations
58K
Open Access
Percentage
43%
Total
Publications
1.9K
Total Open
Publications
829
Total
Citations
58K
Breakdown
Publisher Open
23%
Both
16%
Other Platform Open
4%
Closed
57%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
299
Hybrid 18%
136
No Guarantees 43%
327
Other Platform Open
Domain 78%
308
Other Internet 20%
79
Institution 10%
38
Public 2%
8
Preprint 2%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 307 |
DOI | Other Internet | 78 |
Europe PMC | Domain | 22 |
Hokkaido University - Hokkaido University Collection of Scholarly and Academic Papers | Institution | 7 |
Figshare | Public | 7 |
Research Square | Preprint | 6 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
Nagasaki University - Nagasaki University's Academic Output SITE | Institution | 3 |
DSpace - Kanazawa University Repository for Academic Resources | Institution | 3 |